"Retina Consultants of Texas provides world-class retina care to patients across Houston and beyond. Visit our retina center in Katy to get top retina specialist care for wet & dry macular degeneration (AMD), diabetic retinopathy, retinal tears & detachments, uveitis, flashes & floaters, and more. We offer a full spectrum of retinal diagnostics (fluorescein angiography, etc.) and treatments such as eye injections (Avastin, Lucentis, Eylea), vitrectomy, and scleral buckle. Our retina research center is the largest in the country. We participate in many cutting-edge clinical trials for new & improved retina care. Our retina center in Katy, TX is easily accessible for patients in Fulshear, Sealy, Columbus, Brookshire, and beyond."

During the past decade, Retina Consultants of Houston conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 6 clinical trials were completed, i.e. on average, 54.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Retina Consultants of Houston" #1 sponsor was "Kodiak Sciences Inc" with 4 trials, followed by "Charles C Wykoff, PhD, MD" with 3 trials sponsored, "Amy C Schefler, MD" with 2 trials sponsored, "Greater Houston Retina Research" with 2 trials sponsored and "David M. Brown, M.D." with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Retina Consultants of Houston" #1 collaborator was "Genentech, Inc." with 4 trials as a collaborator, "Regeneron Pharmaceuticals" with 3 trials as a collaborator and "CBCC Global Research" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Retina Consultants of Houston" are "Diabetic Macular Edema" (3 trials), "Radiation Retinopathy" (2 trials), "Age-related Macular Degeneration" (1 trials), "Central Retinal, Hemi Retinal & Brach Retinal Vein Occlusions" (1 trials) and "Choroidal Nevi, Uveal Melanoma" (1 trials). Many other conditions were trialed in "Retina Consultants of Houston" in a lesser frequency.

Most popular intervention types in "Retina Consultants of Houston" are "Drug" (13 trials), "Other" (4 trials), "Procedure" (4 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aflibercept" (7 trials), "KSI-301" (4 trials), "Sham Procedure" (3 trials), "0.5 mg ranibizumab" (2 trials) and "Targeted Pan Retinal Photocoagulation" (2 trials). Other intervention names were less common.

The vast majority of trials in "Retina Consultants of Houston" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Retina Consultants of Houston". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Retina Consultants of Houston, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Retina Consultants of Houston, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".